Ticker Details
MIRUM PHARMACEUTICALS, INC.
IPO Date:	July 12, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.17B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 2.51%
Avg Daily Range (30 D):	$1.75 | 1.91%
Avg Daily Range (90 D):	$1.51 | 1.93%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	.6M
Avg Daily Volume (90 D):	.53M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	1,972
Avg Institutional Trade:	$2.9M
Avg Institutional Trade (30 D):	$7.83M
Avg Institutional Trade (90 D):	$7.01M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.44M
Avg Closing Trade (30 D):	$9.93M
Avg Closing Trade (90 D):	$9.21M
Avg Closing Volume:	84.4K

News

Jan 31, 2026 @ 8:02 PM Is Mirum Pharmaceuticals on a Strong Path to Profi... Source: Prosper Junior Bakiny

Dec 28, 2025 @ 8:11 PM Why a Top Biotech Holder Sold 115,000 Mirum Shares... Source: Jonathan Ponciano

Dec 3, 2025 @ 11:30 AM Prediction: This Stock Has Soared Nearly 70% in 20... Source: Keith Speights

Jun 18, 2024 @ 3:14 PM Mirum (MIRM) Soars on Interim Data From Liver Dise... Source: Zacks Equity Research

Jun 18, 2024 @ 9:46 AM Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Furth... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.85	$.06	$-.12
Diluted EPS	$-.86	$.05	$-.12
Revenue	$471.79M	$133.01M	$127.79M
Gross Profit
Net Income / Loss	$-41.42M	$2.91M	$-5.86M
Operating Income / Loss	$-41.79M	$2.6M	$-4.99M
Cost of Revenue
Net Cash Flow	$56.86M	$53.55M	$14.13M
PE Ratio